Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $732 billion, has been ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...

ST. PAUL, Minn. – Minnesota Attorney General Keith Ellison settled with insulin manufacturers Eli Lilly, Sanofi, and Novo ...

Attorney General Keith Ellison reached a settlement with insulin manufacturers Eli Lilly, Sanofi, and Novo Nordisk, which ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

Minnesota Attorney General Keith Ellison announced on Monday that a settlement has been reached Novo Nordisk over the high ...

US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...

Over the past two years, Eli Lilly has earned approval for such products as Alzheimer's disease ... and fast-acting insulin Humalog. And that's before we get into the company's pipeline, which ...

These drugs have shown remarkable efficacy in treating type 2 diabetes and obesity ... Beyond its GLP-1 franchise, Eli Lilly boasts a diverse portfolio of other key products across various ...